Therapeutic effects of propafenone and verapamil in treatment of paroxysmal supraventricular tachycardia: a comparative study
Xia Wang
Abstract
Xia Wang
Abstract
Objective To investigate the therapeutic effects of propafenone and verapamil in the treatment of paroxysmal supraventricular tachycardia (PST).Methods Eighty PST patients who received treatment in our hospital from March 2009 to March 2011 were included in the study.These patients were equally divided into experimental group and control group using a random number table.The experimental group received propafenone, while the control group received verapamil.Results After treatment, the experimental group had a significantly higher response rate than the control group (90% vs 82.5%, P0.05); in addition, the experimental group had a significantly lower incidence rate of adverse events than the control group (7.5% vs 17.5%, P0.05).Conclusion Propafenone has a better therapeutic effect than verapamil in the treatment of PST.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the therapeutic effects of propafenone and verapamil in the treatment of paroxysmal supraventricular tachycardia (PST).Methods Eighty PST patients who received treatment in our hospital from March 2009 to March 2011 were included in the study.These patients were equally divided into experimental group and control group using a random number table.The experimental group received propafenone, while the control group received verapamil.Results After treatment, the experimental group had a significantly higher response rate than the control group (90% vs 82.5%, P0.05); in addition, the experimental group had a significantly lower incidence rate of adverse events than the control group (7.5% vs 17.5%, P0.05).Conclusion Propafenone has a better therapeutic effect than verapamil in the treatment of PST.
Key concepts: Propafenone, Verapamil, Medicine, Paroxysmal supraventricular tachycardia, Therapeutic effect, Anesthesia, Tachycardia, Internal medicine